All new line-up features Higher Power Density, 99.8% Stability, and Refined Intensity Control.
With LDI-G2, we’re giving researchers brighter illumination, greater stability, and finer control—tools that make demanding imaging experiments more precise and reliable.”
— Julie Martin, Vice President, 89 North
WILLISTON, VT, UNITED STATES, November 14, 2025 /EINPresswire.com/ -- 89 North, an award-winning optical engineering and manufacturing firm based in Vermont, has announced the launch of its LDI-G2 Series, the next generation of its trusted Laser Diode Illuminator family. Designed for researchers pushing the limits of fluorescence and live-cell imaging, the LDI-G2 delivers the intensity, consistency, and precision needed for today’s most demanding microscopy applications.
Building on the proven performance of 89 North’s original LDI platform, the G2 Series
Key features include:
Higher Power Density for Faster, Brighter Imaging
A new single 400µm fiber output concentrates optical power into a smaller area, achieving significantly higher power density and more uniform illumination. The result: faster acquisition speeds, brighter signals, and greater excitation efficiency—without the need for additional homogenization optics. Researchers can now shorten exposure times while maintaining excellent signal-to-background ratios, accelerating imaging for high-content screening, super-resolution microscopy (STORM, PALM, DNA-PAINT), and deep-tissue imaging.
Rock-Solid Stability for Quantitative Confidence
With an upgraded active feedback control system, the LDI-G2 delivers 99.8% illumination stability, ensuring that observed signal changes reflect real biology—not fluctuations in the light source. This level of stability aligns with QUAREP-LiMi WG1 quality standards and makes quantitative imaging and long time-lapse studies more reliable across applications such as calcium imaging, FRAP, FRET, and high-content screening.
Finer Intensity Control for Greater Experimental Precision
LDI-G2 introduces laser power control in 0.1% increments, ten times finer than the industry’s typical 1% step size. Researchers can now finely adjust excitation levels for even the most light-sensitive samples, minimizing photobleaching and phototoxicity while maintaining reproducibility in long-term experiments. Whether imaging live embryos, performing optogenetics, or running overnight imaging studies, LDI-G2 allows scientists to achieve perfectly tuned illumination.
The LDI-G2 Series is available in 4-, 5-, 7-line, and NIR configurations. Technical specifications and downloadable data sheet are available at: www.89north.com/LDI-G2.
About 89 North:
89 North, a wholly owned subsidiary of Chroma Technology, is an award-winning optical engineering design and manufacturing firm located in the Burlington, Vermont area. The company specializes in advanced illumination and imaging systems for life-science, biomedical, and industrial research. 89 North’s expertise in laser and imaging system design is recognized by scientists and engineers worldwide.

No comments:
Post a Comment